Table 2.

Associations Between Individual Adipokine and MHO Status

Adipokines	β	SE	OR (95% CI)	P Value
(A) Adipokines modeled separately
Leptina	−0.44	0.13	0.65 (0.50–0.83)	0.001b
Adiponectina	0.25	0.09	1.28 (1.07–1.54)	0.007b
Leptin/adiponectina	−0.59	0.14	0.56 (0.43–0.73)	<0.001b
Resistina	0.06	0.08	1.06 (0.91–1.23)	0.482
FGF21a	0.00	0.08	1.00 (0.85–1.18)	0.988
RBP‐4a	−0.30	0.09	0.74 (0.62–0.88)	0.001b
Osteonectina	−0.21	0.08	0.82 (0.70–0.96)	0.012b
(B) Adipokines modeled together
Leptin/adiponectina	−0.55	0.15	0.58 (0.43–0.77)	<0.001b
RBP‐4a	−0.26	0.09	0.77 (0.64–0.93)	0.005b
Osteonectina	−0.20	0.09	0.82 (0.70–0.97)	0.021b

Data were natural logarithmically transformed, and all ORs were expressed in standard deviations and adjusted for age, pubertal stages, residence, diet score, physical activity, and body mass index. CI indicates confidence interval; FGF21, fibroblast growth factor 21; OR, odds ratio; RBP‐4, retinol binding protein 4.

^aPer sex‐specific standard deviation increment of each natural logarithmic unit of adipokine.

^b P<0.05.